healthcare business deal

The new collaboration is designed to ensure patients who may face an increased risk of heart disease receive the follow-up care they need.

artificial intelligence pharmaceutical industry

Buzzworthy developments of the past few days.

nonclinical augmented intelligence american medical association

The American Medical Association lays out eight in-demand AI use cases for which the organization says it has heard physicians “express particular enthusiasm.”

artificial intelligence industry watchers digest

Buzzworthy developments of the past few days.

google cloud mayo clinic artificial intelligence

When asked to depict people by various descriptors, the image generator delivered lots of results that were unintentionally hilarious for their wild inaccuracy.

artificial intelligence industry watch

Buzzworthy developments of the past few days.

nvidia artificial intelligence

Here’s what people have been saying about Nvidia’s gradual-then-sudden rise to riches—and what it says about expectations around AI in 2024.  

artificial intelligence in healthcare

Buzzworthy developments of the past few days.

hospitals navigating AI complexities survey

Only 16% of almost three dozen healthcare executives report having a policy for AI governance.

Valentines Data

Buzzworthy developments of the past few days.

artificial intelligence terminology AHA

As AI continues infiltrating healthcare at nearly every level, the technology’s potential for good and ill must become—or remain—a preeminent concern for hospital boards of trustees.

artificial intelligence robot evaluates healthcare data. Novo Nordisk announced a new collaboration with Valo Health, a healthcare technology company focused on using artificial intelligence (AI) technology to identify new drug treatments for cardiovascular disease (CVD).

The new algorithm from Viz.ai is capable of identifying, labeling and quantifying brain bleeds in noncontrast CT images.

Around the web

The new collaboration is designed to ensure patients who may face an increased risk of heart disease receive the follow-up care they need.

The new algorithm from Viz.ai is capable of identifying, labeling and quantifying brain bleeds in noncontrast CT images.

Jeremy Slivnick, MD, spoke with Cardiovascular Business about AI's potential to transform how cardiac amyloidosis is diagnosed and treated.